Dengue fever

Latin America CDC a Must, say Public Health Leaders and AHF

Retrieved on: 
金曜日, 4月 26, 2024

This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.

Key Points: 
  • This new agency would seek to strengthen regional resilience against future health crises through collaboration and resource optimization among nations.
  • Patricia J. Garcia, former health minister of Peru, principal professor of the Faculty of Public Health of the Universidad Peruana Cayetano Heredia, and one of the initiative's proponents, emphasized the importance of this regional collaboration: "The experience with COVID-19 demonstrated critical deficiencies in our public health infrastructure.
  • The LATAM CDC will serve as a fundamental pillar for prevention, preparedness, and rapid response to future health emergencies, thus strengthening our regional health sovereignty."
  • To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/ .

EPA Announces Registration of Groundbreaking New Mosquito Control Solution

Retrieved on: 
火曜日, 4月 23, 2024

This new mosquito control pesticide represents a significant advancement in mosquito control.

Key Points: 
  • This new mosquito control pesticide represents a significant advancement in mosquito control.
  • The WB1 pesticide specifically targets the Aedes aegypti mosquito, commonly known as the Yellow Fever mosquito.
  • "This approach offers targeted, species-specific mosquito control for communities and individuals, while maintaining the high safety standards expected by the EPA," Dobson emphasizes.
  • Effective Mosquito Control: WB1 Males effectively target and reduce populations of Aedes aegypti mosquitoes, the primary transmitter of Dengue fever.

As Public Health Threat of Mosquito-Borne Illness Increases, Florida's World-Class Scientists & Professionals are Ready

Retrieved on: 
月曜日, 4月 15, 2024

Known as the world's deadliest animal, mosquitoes also love Florida, and carry deadly diseases like malaria, West Nile virus, and dengue fever.

Key Points: 
  • Known as the world's deadliest animal, mosquitoes also love Florida, and carry deadly diseases like malaria, West Nile virus, and dengue fever.
  • This week is Florida Mosquito Control Awareness Week , highlighting the incredible science, training and resources dedicated to combating the world's most dangerous animal.
  • Mosquitoes are responsible for more human deaths than any another animal, killing nearly a quarter of a million people globally each year .
  • "It is a true honor to host these passionate, dedicated professionals in Florida," said Dr. Rui-De Xue, AMCD Executive Director.

Akston Biosciences' AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

Retrieved on: 
月曜日, 3月 11, 2024

The study demonstrated AKS-107's potential to target and delete insulin-specific B cells, which are implicated in the development of Type 1 Diabetes (T1D).

Key Points: 
  • The study demonstrated AKS-107's potential to target and delete insulin-specific B cells, which are implicated in the development of Type 1 Diabetes (T1D).
  • AKS-107 is a human IgG1 Fc-fusion protein engineered to retain conformational insulin epitopes that bind to B cell receptors while preventing binding to the insulin metabolic receptor.
  • Regarding its Animal Health applications, Akston is partnered with Dechra Pharmaceuticals PLC to commercialize canine and feline ultra-long insulins.
  • Akston Biosciences Corporation is dedicated to accelerating the next revolution in Animal Health by inventing, developing, and manufacturing breakthrough protein therapeutics for veterinary use.

Friday essay: ‘mourning cannot be an endpoint’ – James Bradley on living in an Age of Emergency

Retrieved on: 
金曜日, 4月 5, 2024

Although it is early, the day is already unseasonably warm, the sky hazy with smoke from hazard-reduction burns to the south and north of the city.

Key Points: 
  • Although it is early, the day is already unseasonably warm, the sky hazy with smoke from hazard-reduction burns to the south and north of the city.
  • Walking to the water’s edge I wade out and dive, then stroke outwards until my breath gives out and I surface with a gasp.
  • There is something very particular about looking back towards the shore from deeper water.
  • Amid the convulsions of COVID, a hastening wave of calamity has made it clear that the first stages of climate breakdown are upon us.
  • Food production will decline markedly, especially in regions such as sub-Saharan Africa, Southeast Asia and Central and South America.
  • Warming and acidifying waters will severely impact the fisheries that provide one-third of the world with their principal source of protein.

A shift

  • Attempting to comprehend its immensity and fluid multiplicity alters us, making it possible to glimpse new continuities and connections.
  • As the late Sven Lindqvist observes in his interrogation of the racist and genocidal foundations of European imperialism, “It is not knowledge we lack.
  • It is the courage to understand what we know and draw conclusions.” In other words, the path through involves more than just a shift in energy sources.
  • It begins in a reckoning with the past, and demands a far more fundamental reorganisation of the global economy, a shift to a model that operates within planetary boundaries and shares resources for the benefit of all.
  • Such a shift is not impossible.

Beauty and astonishment

  • How do we make sense of the disappearance of coral reefs, of dying kelp and collapsing ecosystems?
  • How do we imagine a world in which the massing life that once inhabited not just the oceans but the earth and the sky is largely gone?
  • More than that, however, the act of openness creates the possibility of love and joy and – improbably – wonder.
  • However much has been lost, the world still hums with beauty and astonishment.
  • No less importantly, it is to recognise that despair is also a form of turning away.
  • Yet, like the scientists working to save coral reefs, he said he did not know what else he could do.
  • Instead, grief must be part of a larger recognition that there is no longer any way back, that the only route now is forward.
  • Surviving it demands we build a world that treats everybody – human and non-human – as worthy of life and possibility.
  • I turn to look out to the horizon, its fading margin between sea and sky a space of grief, but also possibility.
  • This is an edited extract from Deep Water: the world in the ocean by James Bradley (Hamish Hamilton).


James Bradley was the recipient of the Copyright Agency Non-Fiction Fellowship for 2020.

Kao and Earth Collaborate in the Field of “Insect (Mosquito) Control” in Thailand

Retrieved on: 
木曜日, 2月 29, 2024

It will be launched in Thailand from July 2024, where Earth has been active domestically for about 40 years.

Key Points: 
  • It will be launched in Thailand from July 2024, where Earth has been active domestically for about 40 years.
  • Earth Corporation founded ARS Chemical (Thailand) Co., Ltd. (now Earth (Thailand) Co., Ltd.) in Thailand in 1980.
  • Earth (Thailand) single-handedly manages development, sales and distribution of, for example, the insect control item brand ARS as a local subsidiary in Thailand.
  • Both Kao and Earth believe that this product will help people living in areas suffering from dengue fever.

Takeda and Biological E. Limited Collaborate to Accelerate Access to Dengue Vaccine in Endemic Areas

Retrieved on: 
火曜日, 2月 27, 2024

Takeda ( TSE:4502/NYSE:TAK ) and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, today announced a strategic partnership to accelerate access to QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs).

Key Points: 
  • Takeda ( TSE:4502/NYSE:TAK ) and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, today announced a strategic partnership to accelerate access to QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003) multi-dose vials (MDVs).
  • These doses will ultimately be made available for procurement by governments in endemic countries by 2030 at the latest to support National Immunization Programs.
  • MDVs offer economic and logistical advantages for National Immunization Programs by minimizing packaging and storage expenses, while also reducing medical and environmental waste.
  • Together, we will help combat dengue on a global scale by significantly increasing manufacturing capacity for multi-dose vials of QDENGA to drive sustainable access to the vaccine in more endemic countries."

Akston Biosciences' AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform's Versatility

Retrieved on: 
月曜日, 2月 26, 2024

This Netherlands study showed the ability of a 90 ug subcutaneous dose to safely boost the immune response of individuals previously primed with a registered mRNA- or adenovirus-based SARS-CoV-2 vaccine.

Key Points: 
  • This Netherlands study showed the ability of a 90 ug subcutaneous dose to safely boost the immune response of individuals previously primed with a registered mRNA- or adenovirus-based SARS-CoV-2 vaccine.
  • Fc-fusion protein vaccines derived from Akston’s platform provide a unique set of benefits, including inherent stability at ambient temperatures and low-cost, high-volume manufacture.
  • AKS-452 is a subunit vaccine consisting of an Fc fusion of the SARS-CoV-2 spike protein receptor binding domain (SP/RBD).
  • “Akston has also made significant strides in demonstrating the Ambifect® platform's potential beyond infectious disease vaccination,” said Todd Zion, Ph.D., President & CEO of Akston Biosciences.

Essential Health and Security Tips for Chinese New Year 2024

Retrieved on: 
木曜日, 2月 1, 2024

With the 2024 Chinese Lunar New Year drawing near, a peak in international travel, as well as domestic travel across China is expected.

Key Points: 
  • With the 2024 Chinese Lunar New Year drawing near, a peak in international travel, as well as domestic travel across China is expected.
  • International SOS , the world's leading health and security risk services company, has issued travel safety tips for the New Year period.
  • Security threats such as fraud and petty theft tend to be more pronounced while travelling and in crowded locations.
  • Enhance Mental Health Resilience: During the holiday and upon returning to work, employees might experience travel-related stress, anxiety or post-holiday blues.

QIAGEN announces partnership with Penn State University to advance microbiome sciences

Retrieved on: 
木曜日, 1月 25, 2024

Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.

Key Points: 
  • Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.
  • In doing so, this new partnership will provide QIAGEN with a site to support the development of new products as a testing center.
  • This includes an internship program for graduate students from Penn State at QIAGEN laboratories at the European operational headquarters in Hilden, Germany, and helps them prepare for careers in the biotechnology industry.
  • “Additionally, it will foster relationships with the microbiome research community and enable us to better develop new products for microbiome research based on direct customer feedback.”
    Seth Bordenstein, Director of the One Health Microbiome Center, Professor of Biology and Entomology, and Huck Endowed Chair in the Microbiome Sciences, at Penn State said: “The ‘One Health’ vision shared by QIAGEN and Penn State University is critical for microbiome research.